CollPlant Biotechnologies Ltd. (CLGN)

Market Cap	5.35M -76.4%
Revenue (ttm)	389,000 -84.3%
Net Income	-13.13M
EPS	-1.03
Shares Out	14.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,928
Open	0.4090
Previous Close	0.3949
Day's Range	0.3700 - 0.4099
52-Week Range	0.2711 - 3.2320
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About CLGN

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue mat...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 39
• Stock Exchange: NASDAQ
• Ticker Symbol: CLGN
• Website: https://collplant.com

Financial Performance

In 2025, CollPlant Biotechnologies's revenue was $2.37 million, an increase of 360.39% compared to the previous year's $515,000. Losses were -$11.49 million, -30.83% less than in 2024.